ELECTROCHEMICAL COFACTOR REGENERATION USING EARTH ABUNDANT ELECTRODES FOR BIOCATALYTIC APPLICATIONS
20240102177 ยท 2024-03-28
Inventors
Cpc classification
C12P3/00
CHEMISTRY; METALLURGY
C25B11/075
CHEMISTRY; METALLURGY
International classification
C25B11/075
CHEMISTRY; METALLURGY
C12P3/00
CHEMISTRY; METALLURGY
Abstract
Embodiments of the present disclosure describe methods and systems using a hydride-forming Group VI transition metal chalcogenide catalyst, such as MoSx, for selective electrocatalysis of enzyme cofactor regeneration. In particular, a method of electrochemical cofactor regeneration comprising: holding an electrode comprising a Group VI transition metal chalcogenide catalyst at a potential sufficient to form a metal hydride in an aqueous electrolyte solution; and contacting the electrode with an oxidized cofactor to reduce the cofactor, is provided. The reduced cofactor can be used by a cofactor-dependent oxidoreductase to convert a substrate to a desired product and subsequently regenerated.
Claims
1. A method of electrochemical cofactor regeneration comprising: holding an electrode comprising a Group VI transition metal chalcogenide catalyst at a potential sufficient to form a metal hydride in an aqueous electrolyte solution; contacting the electrode with an oxidized cofactor to reduce the cofactor.
2. The method of claim 1, wherein the oxidized cofactor is selected from the group consisting of cofactor of NAD.sup.+, NADP.sup.+, FAD.sup.+ and FMN.sup.+ or a combination thereof.
3. The method of claim 1, wherein the potential is held within the range of about ?0.3V to ?0.6 V.
4. The method of claim 1, wherein the Group VI transition metal chalcogenide catalyst has the formula ME.sub.x, where M is a Group VI transition metal, E is a non-metal element, and x is a number greater than 2.
5. The method of claim 4, wherein M is selected from Cr, Mo, and W and/or E is selected from the group of non-metal elements consisting of B, C, N, S, Se, Te, and P.
6. The method of claim 1, wherein the Group VI transition metal chalcogenide catalyst is selected from the group of MoS.sub.x, MoSe.sub.x, WSe.sub.x, and WS.sub.x, wherein x is a number greater than 2.
7. The method of claim 1, wherein the Group VI transition metal chalcogenide catalyst is amorphous.
8. (canceled)
9. The method of claim 1, wherein the aqueous electrolyte solution comprises at least one of potassium phosphate, sodium phosphate and potassium perchlorate.
10. A method of improving the rate of an oxidoreductase-catalyzed reaction comprising: reacting an oxidoreductase and a substrate thereof in the presence of an oxidoreductase cofactor, whereby the substrate is converted to a first product and the cofactor is oxidized; regenerating the oxidized cofactor with an electrode comprising a Group VI transition metal chalcogenide catalyst at a potential sufficient to form a metal hydride, wherein the rate of the reaction is improved compared to the rate of a corresponding oxidoreductase-catalyzed reaction performed without regenerating the oxidized cofactor.
11. The method of claim 10, wherein the oxidoreductase is selected from the group consisting of nicotinamide-dependent oxidoreductases, NADH-dependent oxidoreductases, NADPH-dependent oxidoreductases, and FADH.sub.2-dependent oxidoreductases.
12. The method of claim 11, wherein the oxidoreductase is selected from the group consisting of alcohol dehydrogenases, aldehyde dehydrogenases, ene reductases, amino acid dehydrogenases, oxidoreductases of CHNH groups, nitrate reductases, oxidoreductases acting on a sulfur group, dehydrogenases of diphenols, peroxidases, hydrogenases, oxygenases, monooxygenases, oxidoreductases of metal ions, oxidoreductases acting on CH or CH.sub.2 groups, oxidoreductases of iron-sulfur proteins and of flavodoxin, reductive dehalogenases, and oxidoreductases reducing a COC group.
13. The method of claim 10, wherein the oxidoreductase is conjugated to the electrode.
14. The method of claim 10, wherein the oxidoreductase is solubilized in the aqueous electrolyte solution.
15. The method of claim 10, wherein the electrode is contained in a reaction vessel and the oxidoreductase is separated from the electrode by a membrane.
16. (canceled)
17. The method of claim 10, further comprising a step of: reacting a second enzyme and the first product, whereby the first product is converted to a second product.
18. (canceled)
19. A system for an oxidoreductase-catalyzed reaction comprising: a bioreactor comprising a reaction vessel; wherein the reaction vessel is configured to contain an electrode comprising a Group VI transition metal chalcogenide catalyst and an aqueous electrolyte solution; and configured for regenerating an oxidoreductase cofactor; wherein the bioreactor is configured for reacting the oxidoreductase and a substrate thereof in the presence of the regenerated cofactor, and wherein regenerating the oxidoreductase cofactor includes holding the electrode comprising the Group VI transition metal chalcogenide catalyst at a potential sufficient to form a metal hydride in an aqueous electrolyte solution and contacting the electrode with an oxidized cofactor to reduce the cofactor.
20. The system of claim 19, further comprising a membrane configured to separate the oxidoreductase and the electrode.
21. The system of claim 20, wherein the membrane is a dialysis membrane.
22. The system of claim 20, wherein the oxidoreductase is immobilized on the membrane.
23. The system of claim 19, wherein the oxidoreductase is conjugated to the electrode.
24. (canceled)
Description
BRIEF DESCRIPTION OF DRAWINGS
[0007] The following written disclosure describes various embodiments. Illustrative examples are provided in the accompanying drawings, in which:
[0008]
[0009]
[0010]
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
DETAILED DESCRIPTION
[0042] The present disclosure describes methods and systems using a hydride-forming Group VI transition metal chalcogenide catalyst, such as MoS.sub.x for economical and selective electrocatalysis of cofactor regeneration. The embodiments of the present disclosure are predicated on Applicant's discovery that Group VI transition metal chalcogenides form a hydride active species at cathodic potentials in aqueous solutions. The ability of Group VI transition metal chalcogenide electrocatalysts to form and transfer hydrides in exclusion of single electron transfers opens a cost-effective route for application in biocatalysis and a new paradigm for electrocatalyst design.
[0043] In one embodiment of the present disclosure, a method of electrochemical cofactor regeneration includes holding an electrode comprising a Group VI transition metal chalcogenide at a potential sufficient to form a metal hydride in an aqueous electrolyte solution; and contacting the electrode with an oxidized cofactor to reduce the cofactor. The Group VI transition metal chalcogenide catalysts of the present disclosure are semiconducting and have electrochemical activity for the specific reduction biological redox cofactors, especially but not limited to NAD.sup.+, NADP.sup.+, and FAD(H).sup.+, to their reduced counterparts, namely NADH, NADPH, and FADH.sub.2, respectively. The catalyst can be represented by the formula ME.sub.x, where M is a Group VI transition metal, E is a non-metal element, and x is at least 2, such as 2 or at least 3, 4, or 5. For example, M can be selected from Cr, Mo, and W and/or E can be selected from non-metal elements, such as B, C, N, S, Se, Te, and P. In some cases, the Group VI transition metal chalcogenide is selected the group of MoS.sub.x, MoSe.sub.x, WSe.sub.x, and WS.sub.x. The Group VI transition metal chalcogenide can be amorphous or crystalline.
[0044] The Group VI transition metal chalcogenide catalyst can be deposited, coated, or integrated on a base electrode. The base electrode can be an inert electrode composed of, for example, gold, platinum, glassy carbon, graphite, nanocarbon material, indium-tin oxide (ITO), or fluorine-doped tin oxide (FTO). The base electrode can be a transparent conducting electrode (TCE). The Group VI transition metal chalcogenide catalyst can be coated on the base electrode by any method that provides a redox potential of hydride formation that is more negative than the redox potential of the cofactor to be reduced (i.e., so that the catalyst can hydrogenate the cofactor). For example, the catalyst can be prepared by electrodeposition, sputter-coating, drop-coating, dip-coating or spin-coating.
[0045] In some cases, an electrode of the present disclosure further comprises a conjugated enzyme. For example, the cofactor-dependent oxidoreductase can be conjugated to the surface of the electrode. In some cases, the surface of the catalyst is functionalized with at least one linker group. The linker group can be selected based on based on the non-metal element of the chalcogenide. A suitable linker group can be any bifunctional organic molecule that confers a functional moiety that can be used to immobilize a protein to the catalyst. For example, when the non-metal is sulfur, a suitable linker provide for direct conjugation to the sulfur through CS bond formation. Functional groups on the other end of the linker can be then used to immobilize proteins. See for example,
[0046] The cofactor-dependent oxidoreductase can be directly conjugated to the catalyst. For example, conjugation can be achieved via disulfide-bond formation between the thiol functionality of native or engineered cysteine on the enzyme and a thiol moiety present on the catalyst surface; covalent bond formation between the thiol functionality of an enzyme's native or engineered cysteine and a cysteine-reactive functionality present on the catalyst surface including but not limited to maleimide, haloacteamide, alkene (for radical initiator or photosensitizer promoted thiol-ene reaction) and alkyne (for radical initiator or photosensitizer promoted thiol-yne reaction) linkers; amide bond formation through native or non-native chemical ligation between an enzyme's native or engineered N-terminal cysteine and a thioester present on the catalyst surface; covalent bond formation between the nucleophilic amine functionality of an enzyme's lysine or N-terminus and an electrophilic functionality present on the catalyst surface including but not limited to activated acids (e.g., acyl halides, NHS esters, sulfo-NHS esters, O-acylisourea from carbodiimide-mediated activation of carboxylic acid moieties, and mixed anhydrides or acylimidazols from N,N-carbonyldiimidazole or N,N-disuccinimidyl carbonate mediated activation of carboxylic acid moieties), activated carbamates (e.g. from N,N-carbonyldiimidazole or N,N-disuccinimidyl carbonate mediated activation of amine moieties), activated carbonates (e.g., from N,N-carbonyldiimidazole or N,N-disuccinimidyl carbonate mediated activation of hydroxy moieties), vinyl sulfones, isocyanates, isothiocyanates, and squaric acids; covalent bond formation through imine formation or reductive amination reactions (e.g., in presence of sodium cyanoborohydride) between the nucleophilic amine functionality of an enzyme's lysine or N-terminus and the carbonyl moiety (e.g. of an aldehyde or ketone) present on the catalyst surface; amide bond formation between the carboxylate functionality of an enzyme's aspartate, glutamate or C-terminus activated by conversion with a carbodiimide (e.g. EDC) or phosgene derived (e.g. CDI or DSC) reagent and a nucleophilic functionality present on the catalyst surface including but not limited to amine and alcohol moieties; ester bond formation between the carboxylate functionality of an enzyme's aspartate, glutamate or C-terminus and a diazoalkane or diazoacetyl functionality present on the catalyst surface; bioorthogonal conjugation (e.g. carbonyl condensation, Staudinger ligation, strain-promoted [3+2] cycloaddition, dipolar cycloaddition reactions, inverse electron demand Diels-Alder cycloadditions, transition metal catalyzed cycloadditions, 1,3-photoclick cycloadditions, and transition metal catalyzed CC coupling reactions) between a reactive group on the enzyme introduced by prior chemical conjugation or incorporation of an unnatural amino acid (UAA) and the complementary group present on the catalyst surface.
[0047] In one or more embodiments, the cofactor-dependent oxidoreductase is engineered for conjugation to the catalyst. For example, the enzyme can be synthesized by heterologous expression to include an engineered peptide sequence that facilitates enzymatic conjugation to the catalyst. In some cases the surface of the catalyst is modified with a complementary peptide sequence. For example, the catalyst surface can be modified by methods such as sortase-, subtiligase- and spyLigase-catalyzed transpeptidation; transglutaminase-catalyzed amide-bond formation; and lipoic acid ligase-catalyze acylation.
[0048] In one or more embodiments, the cofactor-dependent oxidoreductase is conjugated to the surface of the catalyst via a biotin/streptavidin-type interaction (e.g., chemical conjugation of biotin with the protein and its binding to a tetrameric streptavidin or streptavidin-like protein; incorporation of a non-canonic amino acid with a biotin side chain into the protein and its and binding to a tetrameric streptavidin or streptavidin-like protein; BirA-catalyzed enzymatic conjugation of biotin with the AviTag? of an correspondingly engineered protein and its binding to a tetrameric streptavidin or streptavidin-like protein; and genetic fusion of a strep-tag type sequence with an protein and its binding to a tetrameric streptavidin or streptavidin-like protein).
[0049] The aqueous electrolyte solution can be configured to stabilize the cofactor-dependent oxidoreductase and permit electrocatalytic cofactor reduction. The electrolyte is primarily composed of water with a conductive ionic species, such as but not limited to potassium phosphate, sodium phosphate, potassium perchlorate, or any other ionic species that can provide conductivity to an aqueous solution. The electrolyte is also conducive to enzyme survival so that enzyme denaturation is substantially inhibited. For example, the concentration of organic solvent is controlled to avoid denaturation. In some cases, the aqueous electrolyte solution has an alkaline or neutral pH. For example, the pH can be maintained between about 6 and about 9. In some cases, the aqueous electrolyte solution contains the cofactor-dependent oxidoreductase. The cofactor-dependent oxidoreductase can be solubilized in the electrolyte solution.
[0050] A Group VI transition metal chalcogenide catalyst of the present disclosure can be used to improve the rate of an oxidoreductase-catalyzed reaction. The rate of the reaction is improved compared to the rate of a corresponding oxidoreductase-catalyzed reaction performed without regenerating the oxidized cofactor. A corresponding reaction is one that is carried out under otherwise identical conditions. The method can include reacting an oxidoreductase and a substrate thereof in the presence of an oxidoreductase cofactor, whereby the substrate is converted to a first product and the cofactor is oxidized and regenerating the oxidized cofactor according to the method described above.
[0051] The oxidoreductase can be selected from the group consisting of nicotinamide-dependent oxidoreductases, NADH-dependent oxidoreductases, NADPH-dependent oxidoreductases, and FADH.sub.2-dependent oxidoreductases. For example, the oxidoreductase can be selected from alcohol dehydrogenases, aldehyde dehydrogenases, ene reductases, amino acid dehydrogenases, oxidoreductases of CHNH groups, nitrate reductases, oxidoreductases acting on a sulfur group, dehydrogenases of diphenols, peroxidases, hydrogenases, oxygenases, monooxygenases, oxidoreductases of metal ions, oxidoreductases acting on CH or CH.sub.2 groups, oxidoreductases of iron-sulfur proteins and of flavodoxin, reductive dehalogenases, and oxidoreductases reducing a COC group.
[0052] A system for practicing the methods of the present disclosure can include a reaction vessel that is configured to contain an electrode comprising a Group VI transition metal chalcogenide catalyst and an aqueous electrolyte solution.
[0053] Turning to
[0054] As shown in
[0055]
[0056]
EXAMPLES
[0057] The following Examples are intended to illustrate the above invention and should not be construed as to narrow its scope. Numerous variations and modifications may be made while remaining within the scope of the invention.
[0058] These examples provide the first direct experimental evidence of an immediate role for Mo in heterogeneous H.sub.2 evolution, placing a paramagnetic Mo center, as opposed to its partner atoms, as an HER-active site with uniquely high activity for hydride formation and transfer. This mechanistic finding also reveals that Mo sulfides have potential as economic electrocatalysts for NADH regeneration in biocatalysis.
Example 1: Mo.SUP.3+ Hydride as the Common Origin of Efficient H.SUB.2 .Evolution and Selective NADH Regeneration Activity in Molybdenum Sulfide Electrocatalysts
Introduction
[0059] Hydride transfers are key to a number of economically and environmentally important reactions, including H.sub.2 evolution and NADH regeneration. Therefore, the electrochemical generation of reactive hydrides has the potential to drive the electrification of chemical reactions to improve their sustainability for a green economy. Catalysts containing molybdenum (Mo) have recently been recognized as amongst the most promising non-precious catalysts for H.sub.2 evolution, but the mechanism of Mo in conferring this activity remains debated. A modified EPR setup was used to demonstrate the presence and catalytic role of a trapped Mo.sup.3+ hydride in amorphous Mo sulfide (a-MoS.sub.x), one of the most active non-noble H.sub.2 evolution catalysts yet reported. The results show that this hydride is active for the selective electrochemical hydrogenation of the biologically important energy carrier NAD to its active NADH form and can, therefore, be utilized for biocatalysis. Furthermore, the data supports applying other HER-active forms of Mo sulfide for biocatalysis.
[0060] Despite the prevalence of Mo in heterogeneous HER electrocatalysts, a direct role for Mo in the reaction (such as the formation of a metal hydride) remained experimentally unresolved. In Mo sulfides, a thiol-like mechanism is instead favored due to the strong hydrogen binding energy of metallic Mo which should lead to poor HER activity (
[0061] This work describes the specific reduction of NAD and its analogue N-methyl nicotinamide (NMN), to their high-energy dihydropyridine derivatives using Mo sulfide catalysts, demonstrating the hydride nature of the MoH bond and its ability to catalyze transfer hydrogenation reactions using water as a hydride source.
Results
[0062] The Mo.sup.3+ hydride species was captured during the electrodeposition of a-MoS.sub.x from MoS.sub.4.sup.2? solutions during cyclic voltammetry (CV), in which MoS.sub.3 is deposited at anodic potentials and subsequently reduced to a-MoS.sub.x at cathodic potentials close to the onset of the HER (
[0063] Although the Mo.sup.3+ EPR signal could be lost upon oxidation, it could also be partly restored if a-MoS.sub.x was reduced in organic electrolyte (0.2 M Bu.sub.4N PF.sub.6/THF,
[0064] Only one major reduction peak was observed during a cathodic sweep from open circuit potential, demonstrating that the resting state of the catalyst was Mo.sup.4+, in line with X-ray photoelectron studies. Coulometric measurements of the reduction event revealed that it corresponded to 40% of the Mo present in the a-MoS.sub.x catalyst as determined by inductively coupled plasma-optical emission spectroscopy (ICP-OES), suggesting that 40% of Mo in a-MoS.sub.x can be converted to the Mo.sup.3+ state. In comparison, the Mo hydride species in freshly deposited a-MoS.sub.x represented 2% of the total Mo as determined by spin counting. Furthermore, by using a-MoS.sub.x electrodes with increasing deposition amounts, the area of the peak as determined using coulometry was found to form a linear correlation with the activity of the a-MoS.sub.x itself as measured by overpotential at ?10 mA cm.sup.?2 in 0.05 M H.sub.2SO.sub.4 (
[0065] The existence of an isotropic Mo.sup.3+ hydride in a-MoS.sub.x provides valuable insights into the structure of the catalyst. For example, Mo.sup.5+ in anodically deposited Mo.sub.3S.sub.13 is coordinated by a number of theoretically equivalent S atoms, but does not have an isotropic EPR signal (
[0066] The role for a hydride intermediate during the HER on a-MoS.sub.x is not just of fundamental interest; Mo hydrides have also been demonstrated as amongst effective non-noble metal hydrogenation catalysts, suggesting that a-MoS.sub.x could be used in electrocatalytic transfer hydrogenation reactions using water as a hydride source, particularly for the biocatalytically-significant recycling of NADH. The reduction of N-methyl nicotinamide (NMN), an analogue of NAD, which is also hydrogenated to a 1,4-dihydropyridine, was then studied. However, NMN is more ideal for distinguishing reduction mechanisms as its single-electron transfer products have distinct spectroscopic (NMR and UV-vis) properties, unlike NAD. Electrochemical reduction of NMN in electrolyte (0.5 M K.sub.2CO.sub.3, pH 10, 5 mM NMN) by a-MoS.sub.x results in a 30 mV positive shift of the onset of catalysis compared to the HER (
[0067] To distinguish the two reduction mechanisms for the reaction on a-MoS.sub.x, UV-visible spectroscopy was used to analyze the NMN electrolyte before and after electrolysis using a-MoS.sub.x. The 1,4-dihydropyridine absorbs strongly at 360 nm while the dimer and its decomposition products have absorption peaks centered at both 360 and 298 nm. The NMN electrolyte gradually formed a peak at 360 nm when electrolyzed with a-MoS.sub.x at a current density of ?10 mA cm.sup.?2 (?=??450 mV) with no prominent features at 298 nm being observed (
[0068] As a final confirmation that a-MoS.sub.x directly reduces NMN to the 1,4-dihydropyridine derivative without proceeding through single-electron transfer, the electrochemical reduction was additionally carried out in both the normal electrolyte as well as deuterated solution (D.sub.2O/K.sub.2CO.sub.3/adjusted to pH 10 using D.sub.2SO.sub.4) followed by nuclear magnetic resonance (NMR) spectroscopy of the isolated product. Deuteration at C4 of NMN should lead to the formation of a CDH motif (
[0069] Based on the ability of a-MoS.sub.x to specifically hydrogenate NMN to its dihydropyridine derivative, the potential of a-MoS.sub.x for NADH regeneration was tested for the enzymatic hydrogenation of benzaldehyde to benzyl alcohol using alcohol dehydrogenase (ADH) from Saccharomyces cerevisiae (
[0070] Since direct NADH regeneration proved promising, the utility of a-MoS.sub.x for direct biocatalysis was tested using the synthesis of benzyl alcohol from benzaldehyde in the presence of enzyme and tenfold excess of benzaldehyde (10 mM) to NAD (1 mM). After 3 hours, 78% conversion was achieved, rising to 87% over 4 hours (
[0071] To confirm that the HER and NAD reduction arise from a common origin and mechanism, the ability of other Mo sulfides to carry out NAD reduction was tested in addition to previous experiments for the HER. Hydrothermally-prepared MoS.sub.2 demonstrated similar activity (76% after 3 hours), but the epitaxially grown and continuously single-crystal (less defective) MoS.sub.2 was inactive (
[0072] Mo.sup.3+ hydride formation has implications for both the HER and NAD regeneration. Traditionally, the primary thiol-based model considered that Mo sulfides evolve H.sub.2 through the recombination of two active hydrogen species (H*, hydrogen with a single electron) on S atoms from thiol-like precursors. However, by demonstrating non-dimerization and high 1,4-dihydropyridine yield for both NAD and NMN, it is clear that a hydride must be the intermediate catalytic species. Furthermore, the loss of H* from a thiol would yield a thiyl radical that should have in turn reacted with the reduced NMN to yield decomposition products, as is the case for NADH. These studies demonstrate the viability of a hydride mechanism by testing the HER activity of ultrathin (5 cycle, to minimize the possible contribution of bulk Mo sulfide) a-MoS.sub.x poisoned by maleimide to inhibit thiol formation. Although x-ray photoelectron spectra (XPS) of the poisoned surfaces suggested that one quarter of all S were poisoned (
[0073] These studies demonstrated that hydride-forming Mo sulfides are economical and selective electrocatalysts for NADH regeneration, in addition to being effective HER catalysts, as a result of the formation of Mo.sup.3+ hydride active species at cathodic potentials in aqueous solutions. The central role of the hydride species in carrying out both reactions as well as the specificity endowed in nicotinamide reduction provides a convincing picture of the mechanism of reactivity of these hydrides for both reactions. Considering the prevalence of Mo amongst effective non-noble HER catalysts, this study justifies the further design and exploration of Mo-based HER catalysts. Finally, the ability of Mo sulfide electrocatalysts to form and transfer hydrides in exclusion of single electron transfers not only opens a cost-effective route for application in biocatalysis, but points to a new strategy and paradigm for electrocatalyst design.
Methods
Materials
[0074] Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich and used as received without further purification except Bu.sub.4N PF.sub.6 (98%, Sigma-Aldrich), which was recrystallized twice from boiling ethanol. Purified THE was acquired from a solvent station. Glassy carbon (GC, 0.0707 cm.sup.2) and all reference electrodes were acquired from ALS Co., Ltd. Gold wire (99.95%) was acquired from The Nilaco Corporation.
General Electrochemistry
[0075] Electrochemical experiments were carried out on a VMP3 Multi-channel or a SP-150 potentiostat (BioLogic). The reference electrode was a Ag/AgCl electrode standardized to the reversible hydrogen electrode (Pt/100% H.sub.2). For organic experiments, the reference electrode was a Ag/Ag.sup.+ electrode (0.01 M AgNO.sub.3/0.1 M Bu.sub.4N PF.sub.6). The working electrodes were GC, with the exception of the EPR cell in which the working electrode was a flattened (0.3?4 cm) Au wire. The counter electrodes were carbon cloth (when GC was used) or Pt (for organic electrochemistry and EPR). All organic electrochemistry experiments were performed in 0.2 M Bu.sub.4N PF.sub.6 using a custom glass electrochemical cell connected to a Schlenk setup to prevent atmospheric contamination. Linear sweep voltammograms for the correlation plot of Mo.sup.3+ and HER activity were collected at 1 mV s.sup.?1, and the three points were collected using a-MoS.sub.x deposited at 10, 20, and 40 cycles, in order of the points from lowest to highest activity. (e.g.,
Electrodeposition of Mo Sulfides
[0076] a-MoS.sub.x was deposited by cyclic voltammetry for 30 cycles from 2 mM (NH.sub.4).sub.2MoS.sub.4/0.1 M NaClO.sub.4. Unless otherwise mentioned, the scans were ended on the cathodic edge (i.e., ?0.95 V vs. Ag/AgCl). To preserve the trapped hydride, the electrode was quickly washed with degassed water and blow-dried with N2 before being placed in a glovebox antechamber. For samples conditioned by LSV, the electrode was scanned once from open circuit potential (post deposition) to ?0.9 V vs. Ag/AgCl in 0.5 M potassium phosphate buffer (pH 7) at 50 mV s.sup.?1. Hydrothermal MoS.sub.2 was prepared by autoclave as previously described. Clean GC carbon stubs were placed into the autoclave for the reaction, which was run for 3 hours at 180? C. The crystal pattern was collected using a Bruker D8 Discovery X-ray diffractometer with Cu K? radiation source. Defect-free MoS.sub.2 was prepared as previously described on a flat GC RDE. (See
Maleimide Experiments
[0077] A water soluble maleimide derivative (1-hexyl-1H-pyrrole-2,5-dione) was prepared by mixing 1.2 mol of maleic anhydride and 1 mol of 6-aminohexanoic acid in 20 mL of acetic acid and heating at 120? C. for 6 h. Extraction was performed by column chromatography as previously reported. Thin (5 cycle) a-MoS.sub.x was used in order to minimize the possibility that catalyst in the bulk of the electrode might be active but could not be poisoned. To functionalize maleimide on the surface of a-MoS.sub.x electrodes, the electrodes were held at ?10 mA cm.sup.?2 for 30 seconds and then immediately placed in 10 mM potassium phosphate (pH 7) with 5 mM maleimide derivative for 2 hours. XPS was collected using a Kratos Axis Supra spectrometer with monochromatic Al K? X-ray source (hv=1486.6 eV) operating at 300 W, multi-channel plate and delay line detector under a vacuum of ?10.sup.?9 mbar. All spectra were recorded using an aperture slot of 300 ?m?700 ?m. Survey spectra were collected using a pass energy of 160 eV and a step size of 1 eV. A pass energy of 20 eV and a step size of 0.1 eV were used for the high-resolution spectra. All binding energies were referenced to the C 1s binding energy of 284.8 eV.
Preparation of N-Methyl Nicotinamide (NMN)
[0078] In a fume hood, nicotinamide was heated to reflux in 10 mL CH.sub.3CN with 3 molar equivalents of CH.sub.3I in a 20 mL disposable glass vial with screw cap. The vapor pressure of CH.sub.3CN is sufficiently low that there is no risk of explosion, although the cap can be loosened at reflux to release accumulated pressure. After a few minutes of heating, the white powder turned yellow, indicating the formation of the N-methylated derivative. The reaction was nonetheless left for 1 h, after which the cap was removed and the liquid evaporated (still in the fume hood). The dry powder was confirmed via NMR to be NMN.
Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES)
[0079] a-MoS.sub.x films were dissolved in 1 mL 70% HNO.sub.3. For complete digestion, the sample was then added to 6 mL of 70% HNO.sub.3 and 1 mL 50% HF followed by microwave digestion in a Milestone digestion oven (150 W, 20 min). Afterwards, the samples were diluted by deionized water to 25 mL before being analyzed on an Agilent 5110 ICP-OES spectrometer.
Electron Paramagnetic Resonance Spectroscopy (EPR)
[0080] After deposition, the Au wire electrode was loaded and sealed into a flat quartz cell (Wilmad-LabGlass) and filled with THE in a glovebox. A X-band continuous wave EMX PLUS spectrometer (Bruker, Rheinstetten, Germany), equipped with standard high sensitivity resonator at 9.795 GHz, was used to collect spectra. The spectra were measured at 20 dB microwave attenuation with 5 G modulation amplitude and 100 kHz modulation frequency. For in situ experiments, this setup was modified by using a conductive electrolyte (0.2 M Bu.sub.4N PF.sub.6/THF) with incorporated reference (Ag/Ag.sup.+) and counter (Pt) electrodes (
Electrochemical Reduction of NMN
[0081] Reductions were carried out in a 40 mL glass reaction cell at a current density of ?10 mA cm.sup.?2. The electrolyte, 0.5 M K.sub.2CO.sub.3/5 mM NMN, was bubbled with Ar throughout the experiment. Control experiments were carried out on bare FTO. UV-vis measurements were carried out using a V-670 spectrophotometer (JASCO). Samples were diluted with deionized water before measurement. For nuclear magnetic resonance spectroscopy (NMR), the reaction was run for four hours, then extracted with ethyl acetate and dried by rotary evaporator under vacuum at room temperature. For deuterated experiments, K.sub.2CO.sub.3 was first dried at 200? C. overnight and kept under anhydrous conditions. D.sub.2O was subsequently used to make the electrolyte. .sup.13C, .sup.2H, and .sup.1H NMR were carried out on 500 and 600 MHz NMR spectrometers (Avance III, Bruker) using CDCl.sub.3 (for .sup.13C and .sup.1H NMR) and CHCl.sub.3 (for .sup.2H NMR). For the starting product, D.sub.2O was used as the solvent.
Electroenzymatic Conversion of Benzaldehyde to Benzyl Alcohol
[0082] In a 4 mL reaction vessel, 2 mL of 0.1 M N-cyclohexyl-2-aminoethanesulfonic acid and 0.1 M K.sub.2SO.sub.4 (pH 9) was used to dissolve 2 ?mol of NAD, 20 ?mol of benzaldehyde, and 5.6 mg of ADH. a-MoS.sub.x was deposited on a double-sided GC electrode (exposed area: 2 cm.sup.2), which was used to electrolyze the solution at ?600 mV vs. RHE. The counter electrode was a glass tube separated from the solution by a Nafion membrane, or a Pt counter electrode was separated from the main compartment by a Nafion membrane with 0.05 M H.sub.2SO.sub.4. Product analysis and quantification was carried out using an Agilent 7890a gas chromatograph/flame ionization detector. A 200 ?L aliquot of reaction solution was mixed with 1 mL of ethyl acetate in a small vial; the ethyl acetate was dried and used for analysis. Enzymatic activity for benzaldehyde hydrogenation was confirmed in the same reaction conditions, but with 2 ?mol of commercially available NADH. Enzymatic NADH quantitation carried out using Promega (Glo) and Sigma Aldrich kits in both the absence and presence of enzyme and benzaldehyde as described in the text. Standard curves were prepared as provided in the Sigma kit, and using commercial NADH for the Promega kit.
NADH and Dimer Detection with Ultrahigh Performance Liquid Chromatography/Mass Spectrometry
[0083] a-MoS.sub.x was used to reduce a 1 mM solution of NAD in ammonium acetate (0.1 M, pH 9) at ?600 mV vs. RHE for 30-60 min. The final solution was diluted with DI water to 1 ?g/mL (?1.5 ?M). A Vanquish UHPLC system coupled to an Orbitrap ID-X Tribrid Mass Spectrometer (Thermo Scientific) using positive mode electrospray ionization was used for analysis. The spectrometer was calibrated using the manufacturer's Calibration Mix ESI and was confirmed to have high resolution (>120,000) and reliable mass accuracy (<5 ppm). Samples (5 ?L each) were infused through a loop injection syringe using a C18 reverse phase column (Agilent, ZORBAX RR Eclipse Plus C18, 2.1?50 mm, 3.5 ?m). The eluents were 4 mM dibutylammonium acetate in 95:5 v/v % water/methanol (eluent A) and 25:75 v/v % water/acetonitrile (eluent B). The elution protocol was as previously reported, where eluent B was initially 0% but raised over 8 min to 80%, 100% over 5 min, held at 100% for 3 min and then back to 0% and held for 5 min. The flow rate was 200 ?L/min.
Example 2: Electrochemical Cofactor Regeneration Using Earth Abundant Electrodes for Biocatalytic Applications
[0084] Biocatalysis provides a unique and specific pathway towards the formation of otherwise difficult-to-attain compounds, especially in the pharmaceutical industry, due to the specificity and enantioselectivity of enzymatic reactions. Enzymes themselves are divided into seven classes based on the type of reaction that they catalyze. Of these, oxidoreductases (EC class 1) constitute one of the largest classes of enzymes (25% of all known enzymes), and are also of interest for biocatalysis as they catalyze reactions that involve electron transfers. The key to utilizing such enzymes in biocatalytic reactions is the provision of cofactors that serve as electron and proton mediators. In the absence of such mediators, these enzymes cannot carry out any reactions. The most common cofactors that constitute the vast majority of cofactors involved in oxidoreductase reactions are molecules based around flavin and nicotinamide structures, both of which are capable of accepting and holding electrons coupled with protons due to their high energy intermediate structures. The most common cofactors are nicotinamide adenine dinucleotide (NAD.sup.+ and its reduced form NADH), required by around 80% of all oxidoreductases, as well as its phosphate-added forms (NADP.sup.+ and NADPH), required by around 10% of all oxidoreductases, and, to a lesser extent, flavin adenine dinucleotide (FAD, and its reduced form FADH.sub.2), also required by around 10% of all oxidoreductases.
[0085] Despite the promise of oxidoreductase-based biocatalysis, the provision of reduced cofactors is prohibitively expensive ($3,000 USD/mol NADH, $215,000 USD/mol NADPH). Such an economic limitation is therefore the key barrier to industrial biocatalytic systems, and the cheap and high yield regeneration of cofactors must be demonstrated before any such processes can be commercialized. Consequently, the regeneration of cofactors is an important field of interest in biotechnology. Broadly, studied approaches for cofactor regeneration fall into several categories. Enzymatic approaches seek to mimic biological approaches to cofactor regeneration by harnessing enzymes normally responsible for cofactor regeneration in the natural world. Other chemical approaches involve reducing cofactors with various reducing agents. Photocatalytic approaches rely on photo-generated reducing power from photocatalysts to reduce cofactor, and similarly, electrocatalytic approaches directly utilize electrical current to reduce cofactors. Each of these approaches is a topic of intense study given the potential value of an economical means for cofactor regeneration. In all cases, trade-offs between cost/yield (especially enzymatic, but also chemical) and specificity (photocatalytic, electrocatalytic) mean that limitations remain.
[0086] If the specificity challenge can be met, electrochemical approaches show the most theoretical promise as they can provide regeneration at high and controllable rates, with good processing. The problem of specificity arises from the fact that cofactors can be reduced by different mechanisms depending on the role of electrons and hydrides. For example, a one electron reduction of NAD.sup.+ will lead to the dimerization and irreversible decomposition of NAD. Specific transfer of hydrides (two electrons, one proton) is therefore a necessary requirement for successful and long-lasting electrochemical cofactor regeneration. On many metallic surfaces, electron transfer is far easier than hydride formation and transfer, and so conventional electrochemical approaches have so far proven mostly unsuccessful or rely on good hydride forming metals, mainly noble metals which are not economical for scale-up.
[0087] These examples detail use of Group VI compounds (comprising a Group VI element, Cr, Mo, W, and a second non-metal element, namely C, B, P, S, Se, Te, N) as catalysts for cofactor regeneration. These catalysts have several advantages. First, they exclusively form hydrides before they transfer electrons freely as a result of their semiconducting nature. Therefore, they are very specific for cofactor regeneration. Second, although these catalysts can be used with proteins in soluble form, the presence of a second element (the chalcogenide) with defined linker chemistries allows direct protein conjugation to the catalyst without affecting and/or blocking active sites. Finally, these catalysts are composed of earth abundant elements and so their preparation and scale-up is cheap and inexpensive, especially compared to hydride forming catalyst like platinum, gold, or ruthenium-iridium coated titanium. By combining Group VI catalysts in different configurations, it is possible to carry out complicated biocatalytic reactions and cascades in an economically feasible way.
Reduction of N-Methylnicotinamide, an Analog of NAD+, by a-MoS.sub.x, a Catalyst Deposited on an Electrode.
[0088] A fluorine-doped tin oxide (FTO) electrode was used for reduction of N-methylnicotinamide.
Reduction of NAD+ for Use by Immobilized Alcohol Dehydrogenase (ADH).
[0089]
[0090] As shown in
[0091] ADH was immobilized on the surface of the electrode, operated in electrolyte with NAD+ and benzaldehyde. After 1 h, 10% of the benzaldehyde was converted to benzyl alcohol as determined by GC-MS (
[0092] The Examples above should not be construed as limiting the scope of the disclosure, but as merely providing illustrations of some of the embodiments of this disclosure. The example embodiments, as described above, were chosen and described in order to best explain the principles of the disclosure and its practical application to thereby enable others skilled in the art to best utilize the disclosure in various embodiments and with various modifications as are suited to the particular use contemplated. Various combinations or sub-combinations of specific features and aspects of the embodiments fall within the scope of this disclosure. Various features and aspects of the disclosed embodiments can be combined with or substituted for one another. The scope of the disclosure is defined by the claims appended hereto.